{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:54:28Z","timestamp":1793386468279,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005642","name":"Universit\u00e0 degli Studi di Sassari","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005642","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Spine J"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To determine benefits and adverse effects (AE) of oral muscle-relaxants (MR) (non-benzodiazepines) for acute (&lt;\u20096\u00a0weeks) and chronic (&gt;\u200912\u00a0weeks) primary LBP, administered alone or combined with analgesics\/NSAIDs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>CENTRAL, MEDLINE, EMBASE, CINAHL were searched for pertinent randomized controlled trials. Primary outcomes comprised lack of pain relief, global efficacy and AE at 5\u20137 days follow-up assessed dichotomously (risk ratio, RR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Fifty studies (7531 participants) were included, with data from 4775 pooled in meta-analyses. For acute LBP, non-benzodiazepine MR\u00a0were associated with increased likelihood of pain relief (moderate certainty; RR: 0.53,\u00a0\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001), global efficacy (RR: 0.49,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0001), muscle spasm (RR: 0.62,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.00001), and physical outcomes (RR: 0.60,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.00001) compared to placebo. AE were more frequent with non-benzodiazepine MR\u00a0compared to placebo (low-to-moderate certainty; RR: 1.56;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003), and at central nervous system (CNS; RR: 2.40;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.00001), but not at gastrointestinal (GI) level (RR: 0.77;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.62). Combined non-benzodiazepines\u2009+\u2009analgesics\/non-steroidal anti-inflammatory drugs (NSAIDs) provide a larger and clinically meaningful benefit compared to placebo\u2009+\u2009analgesics\/NSAIDs for global efficacy at 5\u20137 days (low-certainty; RR: 0.62;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.01). Combined therapy did not result in significant between-group differences for total AE (moderate-certainty; RR: 1.15;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.50) and GI AE (RR: 0.63;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.08), despite responsible for more CNS AE (low-certainty; RR: 1.91;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002). When comparing non-benzodiazepine MR versus placebo for chronic LBP, only data on total AE could be pooled, without between-group difference (RR: 0.93;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.69).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Non-benzodiazepine MR for acute LBP were associated with increased likelihood of pain relief\u00a0and global efficacy compared to placebo. Combined therapy with analgesics\/NSAIDs proved superior for global efficacy. Studies are needed to evaluate if non-benzodiazepine MR\u00a0are of larger benefit than analgesics\/NSAIDs, and if stand-alone administration provides more benefit than combined treatment. The observed AE warrant caution.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00586-025-08786-0","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T22:35:27Z","timestamp":1743892527000},"page":"2347-2366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Oral non-benzodiazepine muscle-relaxants for people with acute and chronic primary low back pain: a systematic review with meta-analysis"],"prefix":"10.1007","volume":"34","author":[{"given":"Andrea","family":"Manca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Cugusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurits","family":"van Tulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Furlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Solla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Monticone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,5]]},"reference":[{"issue":"7","key":"8786_CR1","doi-asserted-by":"publisher","first-page":"514","DOI":"10.7326\/M16-2367","volume":"166","author":"A Qaseem","year":"2017","unstructured":"Qaseem A, Wilt TJ, McLean RM, Forciea MA (2017) Clinical Guidelines Committee of the American. College of Physicians. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Ann Internal Med 166(7):514\u2013530","journal-title":"Ann Internal Med"},{"issue":"2","key":"8786_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/01.mjt.0000134786.50087.d8","volume":"12","author":"FA Beebe","year":"2005","unstructured":"Beebe FA, Barkin RL, Barkin S (2005) A clinical and pharmacologic review of skeletal muscle relaxants for musculoskeletal conditions. Am J Ther 12(2):151\u2013171","journal-title":"Am J Ther"},{"issue":"2","key":"8786_CR3","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/ejp.907","volume":"21","author":"C Abdel Shaheed","year":"2017","unstructured":"Abdel Shaheed C, Maher CG, Williams KA, McLachlan AJ (2017) Efficacy and tolerability of muscle relaxants for low back pain: systematic review and meta-analysis. Eur J Pain 21(2):228\u2013237","journal-title":"Eur J Pain"},{"key":"8786_CR4","doi-asserted-by":"publisher","first-page":"n1446","DOI":"10.1136\/bmj.n1446","volume":"374","author":"AG Cashin","year":"2021","unstructured":"Cashin AG, Folly T, Bagg MK et al (2021) Efficacy, acceptability, and safety of muscle relaxants for adults with non-specific low back pain: systematic review and meta-analysis. BMJ 374:n1446. https:\/\/doi.org\/10.1136\/bmj.n1446","journal-title":"BMJ"},{"issue":"2\u20133","key":"8786_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0304-3959(96)03032-1","volume":"66","author":"A Moore","year":"1996","unstructured":"Moore A, McQuay H, Gavaghan D (1996) Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics. Pain 66(2\u20133):229\u2013237","journal-title":"Pain"},{"issue":"1","key":"8786_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12998-022-00435-3","volume":"30","author":"MR Price","year":"2022","unstructured":"Price MR, Cupler ZA, Hawk C, Bednarz EM, Walters SA, Daniels CJ (2022) Systematic review of guideline-recommended medications prescribed for\u00a0treatment of low back pain. Chiropr Man Therap. 30(1):26. https:\/\/doi.org\/10.1186\/s12998-022-00435-3","journal-title":"Chiropr Man Therap."},{"issue":"4","key":"8786_CR7","doi-asserted-by":"publisher","first-page":"CD013815","DOI":"10.1002\/14651858.CD013815.pub2","volume":"4","author":"AG Cashin","year":"2023","unstructured":"Cashin AG, Wand BM, O\u2019Connell NE et al (2023) Pharmacological treatments for low back pain in adults: an overview of cochrane reviews. Cochrane Database Syst Rev 4(4):CD013815. https:\/\/doi.org\/10.1002\/14651858.CD013815.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"8786_CR8","first-page":"CD004252","volume":"2","author":"MW van Tulder","year":"2003","unstructured":"van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM (2003) Muscle relaxants for non-specific low back pain. Cochr Database System Rev 2:CD004252","journal-title":"Cochr Database System Rev"},{"key":"8786_CR9","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jclinepi.2021.03.001","volume":"134","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. J Clin Epidemiol 134:178\u2013189","journal-title":"J Clin Epidemiol"},{"issue":"21","key":"8786_CR10","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1097\/BRS.0000000000001061","volume":"40","author":"AD Furlan","year":"2015","unstructured":"Furlan AD, Malmivaara A, Chou R, Maher CG, Deyo RA, Schoene M, Bronfort G, van Tulder MW (2015) Updated method guideline for systematic reviews in the cochrane back and neck group. Spine (Phila Pa 1976) 40(21):1660\u20131673","journal-title":"Spine (Phila Pa 1976)"},{"key":"8786_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA (2011) The Cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928","journal-title":"BMJ"},{"key":"8786_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","volume":"94","author":"JT Farrar","year":"2001","unstructured":"Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole RM (2001) Clinical importance of changes in chronic pain intensity measured on an 11-point numerical rating scale. Pain 94:149\u2013158","journal-title":"Pain"},{"issue":"1","key":"8786_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/BRS.0b013e31815e3a10","volume":"33","author":"RW Ostelo","year":"2008","unstructured":"Ostelo RW, Deyo RA, Stratford P, Waddell G, Croft P, Von Korff M, Bouter LM, de Vet HC (2008) Interpreting change scores for pain and functional status in low back pain: towards international consensus regarding minimal important change. Spine (Phila Pa 1976) 33(1):90\u201394","journal-title":"Spine (Phila Pa 1976)"},{"key":"8786_CR14","unstructured":"Sch\u00fcnemann HJ, Vist GE, Higgins JPT, Santesso N, Deeks JJ, Glasziou P, Akl EA, Guyatt GH (2022) Chapter 15: interpreting results and drawing conclusions. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (eds) Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022), vol section-15-4. Cochrane"},{"issue":"3","key":"8786_CR15","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jphys.2023.05.012","volume":"69","author":"SE Brennan","year":"2023","unstructured":"Brennan SE, Johnston RV (2023) Research note: interpreting findings of a systematic review using GRADE methods. J Physiother 69(3):198\u2013202. https:\/\/doi.org\/10.1016\/j.jphys.2023.05.012","journal-title":"J Physiother"},{"issue":"5","key":"8786_CR16","first-page":"646","volume":"32","author":"R Barrata","year":"1982","unstructured":"Barrata R (1982) A double-blind study of cyclobenzaprine and placebo in the treatment of acute muskuloskeletal conditions of the low back. Curr Ther Res 32(5):646\u2013652","journal-title":"Curr Ther Res"},{"key":"8786_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/030006058801600201","volume":"16","author":"H Berry","year":"1988","unstructured":"Berry H, Hutchinson D (1988) A multicentre placebo-controlled study in general practice to evaluate the efficacy and safety of tizanidine in acute low-back pain. J Int Med Res 16:75\u201382","journal-title":"J Int Med Res"},{"issue":"4","key":"8786_CR18","first-page":"454","volume":"26","author":"P Lepisto","year":"1979","unstructured":"Lepisto P (1979) A comparative trial of dS 103\u2013282 and placebo in the treatment of acute skeletal muscle spasms due to disorders of the back. Therap Res 26(4):454\u2013459","journal-title":"Therap Res"},{"issue":"7","key":"8786_CR19","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/j.1742-1241.2004.00454.x","volume":"59","author":"A Ketenci","year":"2005","unstructured":"Ketenci A, Ozcan E, Karamursel S (2005) Assessment of efficacy and psychomotor performances of thiocolchicoside and tizanidine in patients with acute low back pain. Int J Clin Pract 59(7):764\u2013770","journal-title":"Int J Clin Pract"},{"issue":"5","key":"8786_CR20","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/S1297-319X(03)00075-7","volume":"70","author":"F T\u00fcz\u00fcn","year":"2003","unstructured":"T\u00fcz\u00fcn F, Unalan H, Oner N, Ozg\u00fczel H, Kirazli Y, I\u00e7a\u011fasio\u011flu A, Kuran B, T\u00fcz\u00fcn S, Ba\u015far G (2003) Multicenter, randomized, double-blinded, placebo-controlled trial of thiocolchicoside in acute low back pain. Joint Bone Spine 70(5):356\u2013361","journal-title":"Joint Bone Spine"},{"key":"8786_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1177\/030006058801600202","volume":"16","author":"H Berry","year":"1988","unstructured":"Berry H, Hutchinson D (1988) Tizanidine and Ibuprofen in acute low-back pain: Results of a double-blind multicentre study in general practice. J Int Med Res 16:83\u201391","journal-title":"J Int Med Res"},{"issue":"15","key":"8786_CR22","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1001\/jama.2015.13043","volume":"314","author":"BW Friedman","year":"2015","unstructured":"Friedman BW, Dym AA, Davitt M, Holden L, Solorzano C, Esses D, Bijur PE, Gallagher EJ (2015) Naproxen with cyclobenzaprine, oxycodone\/acetaminophen, or placebo for treating acute low back pain: a randomized clinical trial. J Am Med Assoc 314(15):1572\u20131580","journal-title":"J Am Med Assoc"},{"issue":"3","key":"8786_CR23","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.annemergmed.2017.09.031","volume":"71","author":"BW Friedman","year":"2018","unstructured":"Friedman BW, Cisewski D, Irizarry E, Davitt M, Solorzano C, Nassery A, Pearlman S, White D, Gallagher EJ (2018) A randomized, double-blind, placebo-controlled trial of naproxen with or without orphenadrine or methocarbamol for acute low back pain. Ann Emerg Med 71(3):348\u2013356","journal-title":"Ann Emerg Med"},{"issue":"4","key":"8786_CR24","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.annemergmed.2019.02.017","volume":"74","author":"BW Friedman","year":"2019","unstructured":"Friedman BW, Irizarry E, Solorzano C et al (2019) A randomized, placebo-controlled trial of ibuprofen plus metaxalone, tizanidine, or baclofen for acute low back pain. Ann Emerg Med 74(4):512\u2013520. https:\/\/doi.org\/10.1016\/j.annemergmed.2019.02.017","journal-title":"Ann Emerg Med"},{"issue":"1","key":"8786_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0011-393X(98)85019-4","volume":"59","author":"Sirdalud Ternelin Asia-Pacific Study Group","year":"1998","unstructured":"Sirdalud Ternelin Asia-Pacific Study Group (1998) Efficacy and gastroprotective effects of tizanidine plus diclofenac versus placebo plus diclofenac in patients with painful muscle spasms. Curr Ther Res 59(1):13\u201322","journal-title":"Curr Ther Res"},{"issue":"2","key":"8786_CR26","first-page":"125","volume":"12","author":"D Borenstein","year":"1990","unstructured":"Borenstein D, Lacks S, Wiesel S (1990) Cyclobenzaprine and naproxen versus naproxen alone in the treatment of acute low back pain and muscle spasm. Clin Ther 12(2):125\u2013131","journal-title":"Clin Ther"},{"issue":"11","key":"8786_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.17116\/jnevro201711711169-78","volume":"117","author":"ML Kukushkin","year":"2017","unstructured":"Kukushkin ML, Brylev LV, Laskov VB, Makarov NS, Pizova NV, Sokov EL, Chefranova ZY, Sholomov II, Guekht AB (2017) Results of a randomized double blind parallel study on the efficacy and safety of tolpersione in patients with acute nonspecific low back pain. Zhurnal Nevrologii i Psihiatrii imeni S.S.Korsakova 117(11):69\u201378","journal-title":"Zhurnal Nevrologii i Psihiatrii imeni S.S.Korsakova"},{"issue":"35\u201336","key":"8786_CR28","first-page":"500","volume":"114","author":"R Worz","year":"1996","unstructured":"Worz R, Bolten W, Heller J, Krainick U, Pergande G (1996) Flupirtine in comparison with chlormezanone in chronic musculoskeletal back pain. Results of a multicenter randomized double-blind study [Flupirtin im vergleich zu chlormezanon und placebo bei chronische muskuloskelettalen ruckenschmerzen]. Fortschritte der Therapie 114(35\u201336):500\u2013504","journal-title":"Fortschritte der Therapie"},{"key":"8786_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/0304-3959(96)03187-9","volume":"67","author":"HG Pratzel","year":"1996","unstructured":"Pratzel HG, Alken R-G, Ramm S (1996) Efficacy and tolerance of repeated oral doses of tolperisone hydrochloride in the treatment of painful reflex muscle spasm: results of a prospective placebo-controlled double-blind trial. Pain 67:417\u2013425","journal-title":"Pain"},{"issue":"10","key":"8786_CR30","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1185\/03007995.2012.726216","volume":"28","author":"MA Uberall","year":"2012","unstructured":"Uberall MA, Mueller-Schwefe GH, Terhaag B (2012) Efficacy and safety of flupirtine modified release for the management of moderate to severe chronic low back pain: results of SUPREME, a prospective randomized, double-blind, placebo- and active-controlled parallel-group phase IV study. Curr Med Res Opin 28(10):1617\u20131634","journal-title":"Curr Med Res Opin"},{"issue":"10","key":"8786_CR31","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1016\/j.pain.2011.06.003","volume":"152","author":"R Emshoff","year":"2011","unstructured":"Emshoff R, Bertram S, Emshoff I (2011) Clinically important difference thresholds of the visual analog scale: a conceptual model for identifying meaningful intraindividual changes for pain intensity. Pain 152(10):2277\u20132282","journal-title":"Pain"}],"container-title":["European Spine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-025-08786-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00586-025-08786-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-025-08786-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:33:01Z","timestamp":1751355181000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00586-025-08786-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,5]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["8786"],"URL":"https:\/\/doi.org\/10.1007\/s00586-025-08786-0","relation":{},"ISSN":["0940-6719","1432-0932"],"issn-type":[{"value":"0940-6719","type":"print"},{"value":"1432-0932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,5]]},"assertion":[{"value":"5 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}